We are a consumer health company focused on marketing ZanthoSyn®, a physician recommended astaxanthin dietary supplement for inflammatory health.* ZanthoSyn® is available through our commercial website, www.zanthosyn.com.

We aim to build consumer sales with a reduced corporate cost structure to improve operating cash flow and achieve profitability.

While we also believe in the value of our pharmaceutical program, attempts to finance its continued development have been unsuccessful to date. We may seek to monetize our pharmaceutical assets through licensing or sale.

Other strategic alternatives are also under consideration.

We believe our products have competitive advantages primarily related to a unique combination of the following benefits:

  • Excellent safety profile that supports chronic use
  • Anti-inflammatory activity and pleiotropic effects with broad health applications
  • Oral dosing convenience
  • Scalable manufacturing
  • Economical pricing